Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
PHASE2
This is a phase II single-arm single-stage study evaluating efficacy and sa...
Status
Active Not Recruiting
Location
Maria Sklodowska-Curie National Research Institute of Oncology
Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC
PHASE2
Evaluate the safety and efficacy of the combination of eftilagimod alpha wi...
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)
PHASE3
The purpose of this study is to compare eftilagimod alfa (efti) in combinat...